Increasing drug prices are harming tens of millions of Americans

It can be difficult to get basic information and resources on the problem. Below are a number of helpful resources, groups dedicated to reducing prices, and general information. Consumer Letter in Support of the CREATES Act  21 Incredibly Disturbing Facts About High Prescription Drug Prices​Do Drug Benefit Managers Reduce Health Costs?​A Tangled Web: An Examination of the Drug Supply and Payment Chains​Overpatented, Overpriced: How Excessive Pharmaceutical Patenting is Extending Monopolies and Driving Up Drug Prices​Overpatented, Overpriced Special Edition: Lantus (insulin glargine)​The Lobbyist Who Made You Pay More At the Drugstore by Wendell Potter​Addressing Out of Control Prescription Drug Prices: Federal and State Strategies​Battling High Prescription Drug Prices​Curbing Unfair Drug Prices: A Primer for States​Personal Stories of Individuals Harmed by High Drug Prices: Collected by Patients for Affordable Drugs ​How Medicaid and CHIP Shield Children from the Rising Costs of Prescription Drugs​Drawing a Line in the Sand: Employers Must Rethink Pharmacy Benefit Strategies​Guest Opinion: Make Lawmakers Cut Kickbacks, Hold Drug Companies Accountable​March 1, 2019 Letter from the Alliance for Retired Americans, Consumer Action, Consumer Federation of America, Medicare Rights Center, National Consumers League, Patients for Affordable Drugs NOW, and U.S. PIRG to the Centers for Medicare and Medicaid Services in support of CMS call letter and measures to lower out of pocket costs for generic drugs February 27, 2019 Letter to Speaker Nancy Pelosi, Rep. Richard Neal and Rep. Rank Pallone about the urgency of taking action to lower prescription drug prices December 3, 2018 Comments from Consumer Action, Consumer Reports, Patients for Affordable Drugs NOW, Public Citizen, and the U.S. PIRG Education Fund to the Food and Drug Administration, urging the FDA to ensure citizen petitions aren’t abused by drug companies to block access to more affordable medicines October 23, 2017 Letter from Consumer Action, Consumer Federation of America, Consumers Union, Families USA, Patients for Affordable Drugs, Public Citizen, US PIRG, and the Law Offices of David Balto to Chairwoman Maureen Ohlhausen and Commissioner Terrell McSweeny of the Federal Trade Commission, urging the FTC to investigate Allegeran’s transfers of Restasis patents to the Saint Regis Mohawk Tribe  October 19th, 2017 Letter from Healthcare Providers, Public Health Experts, People of Faith, Consumers, Businesses, and Taxpayers to Senators Chuck Grassley, Dianne Feinstein, Mike Lee, and Amy Klobuchar urging investigation of Allergan’s transfer of Restasis patents to the Saint Regis Mohawk Tribe  October 10th, 2017 Letter from Physicians, Healthcare Providers, and Companies to House Speaker Paul Ryan, House Minority Leader Nancy Pelosi, Senate Majority Leader Mitch McConnell, and Senate Minority Leader Chuck Schumer urging investigation of Allergan’s transfer of Restasis patents to the Saint Regis Mohawk Tribe  September 27, 2017 Letter from Senators Margaret Hassan, Sherrod Brown, Robert Casey, and Richard Blumenthal to the Senate Judiciary Committee urging investigation of Allergan’s transfer of Restasis patents to the Saint Regis Mohawk Tribe​September 18, 2017 Letter from Consumer Action, Consumer Federation of America, Consumers Union, and Patients for Affordable Drugs to the Food and Drug Administration on the need to end abuses of the FDA’s regulatory process that block access to generic drugs August 17, 2017 Letters from Representatives Elijah Cummings and Peter Welch to Bayer Healthcare, Biogen, EMD Serono, Novartis Pharmaceuticals Corporation, Sanofi Genzyme, Teva Pharmaceutical Industries, and Roche Pharmaceuticals requesting information about the price increases of MS drugs June 27, 2017 Letter from National Community Pharmacists Association to the Office of Management and Budget urging investigation of pharmacy benefit managers  June 23, 2017 Letter from Senators Al Franken, Sheldon Whitehouse, Elizabeth Warren, Tom Udall, Jack Reed, Bernie Sanders, Margaret Hassan, and Sherrod Brown to President Donald Trump urging policies to reduce drug prices June 21, 2017 Letter from Representatives Elijah Cummings and Peter Welch to President Donald Trump urging policies to reduce drug prices  June 13, 2017 Testimony before the Senate Health, Education, Labor, and Pensions Committee on drug prices June 12, 2017 Letter from Consumer Action urging the Senate Health, Education, Labor, and Pensions Committee to investigate PBMs May 16, 2017 Letter from Consumers Union, Consumer Federation of America, Consumer Action, Consumer Watchdog, and U.S. PIRG in support of the Medicare Prescription Drug Price Negotiation Act of 2017 ​May 15, 2017 Letter from Representatives in support of legislation reducing drug prices in context of UFAs​April 24, 2017 An Open Letter to Congress in Support of Legislation to Improve Access to Affordable Prescription Drugs ​February 14, 2017 Letter from Senators Chuck Grassley, John McCain, and Amy Klobuchar urging HHS importation of prescription drugs from Canada​December 20, 2016 Letter from Senators Sherrod Brown and Al Franken outlining steps to bring down prescription drug costs ​July 12, 2016 Letter from American Consumer Institute, Consumer Action, Consumer Watchdog, Public Citizen, and Taxpayers for Common Sense in support of the CREATES Act​July 14, 2015 Letter from Consumers Union, Consumer Watchdog, Consumer Federation of America, Community Catalyst, Consumer Action, U.S. PIRG, National Center for Health Research, and Public Citizen against generic drug manufacturer consolidationDecember 2017 Americans Say They Are Suffering as Drug Costs Continue to Rise by Consumer Reports November 2017 PBM DIR Fees Costing Medicare and Beneficiaries: An Investigative White Paper on Background, Cost Impact, and Legal Issues by Frier Levitt August 2017 Curbing Unfair Drug Prices: A Primer for States by the Yale Global Health Justice Partnership, the National Physicians Alliance, and the Universal Health Care Foundation of Connecticut  May 2017 Unaccountable Benefit Managers: Real Horror Stories of How PBMs Hurt Patient Care by the Community Oncology Alliance and the Community Oncology Pharmacy Association  May 2017 Selective Transparency: Transparency Efforts Obscure Real Health Care Pricing Issues by the Institute for Policy Innovation  May 8, 2017 Why Our Drugs Cost So Much by AARP​March 2017 Pharmacy Benefit Managers: Market Power and Lack of Transparency by the American Consumer Institute  September 2016 Negotiation Plus: A Framework for Value Based Drug Negotiation by the Center for American Progress ​August 2016 Promoting Access to Affordable Prescription Drugs: Policy Analysis and Consumer Recommendations for State Policymakers, Consumer Advocates, and Healthcare Stakeholders July 29, 2016 Is There A Cure for High Drug Prices? by Consumer Reports​September 2015 Enough is Enough: The Time Has Come to Address Sky-High Drug Prices by the Center for American Progress ITC Comcast Patent Consumer Groups and Unions Submit Letter Expressing Concerns that Divestitures Won’t Remedy Merger’s Anticompetitive Effects – 2.18.2020 Consumer Groups and Unions Submit Letter in Support of Bill Regulating PBMs and Lowering Drug Prices – 12.16.2019 Manar Says PBM Bill Will Save Taxpayers Millions – 12.12.2019 House Votes to Give the Government the Power to Negotiate Drug Prices – 12.12.2019 Pelosi Drug Pricing Plan Would Save $456 Billion Over 10 Years: Analysis – 12.10.2019 Do Large Pharma Companies Provide Drug Development Innovation? Our Analysis Says No – 12.10.2019 Solicitor General Asks U.S. Supreme Court to Hear Arkansas PBM Case – 12.6.2019 Rep. Schrader Introduces Bill to Increase Drug Price Transparency and Reduce Gaming – 12.5.2019 House to Vote on Pelosi Drug Pricing Bill Next Week – 12.5.2019 The Most Viable Drug Pricing Bill in Congress Is Getting A Makeover – 12.5.2019​Trump’s Drug Importation Plan Faces Resistance in US, Canada – 12.1.2019 Ohio Accuses Drug Company of Overcharging for Prescriptions – 11.27.2019​Changes Coming to Grassley-Wyden Drug Bill – 11.22.2019 Pennsylvania House Passes Matzie Bill Making Pharmacy Benefit Managers’ Practices More Transparent – 11.21.2019 Ohio Medicaid Still Hemorrhaging Money to Pharmacy Middlemen, Expert Testifies – 11.21.2019​’Hipster Antitrust’ Might End the Megamerger Party – 11.19.2019 Top GOP Senator; Drug Pricing Action Unlikely Before End of Year – 11.19.2019 Booker and Sanders Propose a New Federal Agency to Set Drug Prices – 11.15.2019 Legal Challenges Against State PBM Laws May Culminate In Supreme Court Review – 11.14.2019  Voters Say Congress  Needs to Curb Drug Prices, But Are Lawmakers Listening? – 11.11.2019 Ohio Lawmaker Proposes Sweeping Restrictions on Pharmacy Middlemen – 11.8.2019​House Vote on Pelosi Drug Pricing Plan Slips To November – 11.6.2019 White House and Pelosi Part Ways on Relief for Drug Prices – 11.5.2019 FDA’s Proposed Rule on Drugs Lands At OMB – 11.4.2019 Drug Rebate Dollars Continue to Rise – 11.1.2019 House Democrats Clash Over Pelosi’s Drug Pricing Bill – 10.30.2019 House Passes Spanberger Bill to Bring Transparency to Prescription Drug Negotiations – 10.29.2019​Independent Pharmacies Being Driven Out of Business By ‘Predatory Middlemen’ – 10.21.2019 It’s Hard to Lower Drug Prices, If You Don’t Know What They Are – 10.19.2019 As Pharmacies Dwindle, Multiple Counties Left in Prescription Drug Desert – 10.17.2019 Key House Committee Passes Speaker Nancy Pelosi’s Sweeping Drug Pricing Bill – 10.17.2019 CBO Says House Speaker Nancy Pelosi’s Drug Pricing Plan Saves Medicare $345 Billion Over Decade – 10.14.2019 California’s New Transparency Law Reveals Steep Rise in Wholesale Drug Prices – 10.11.2019 2020 Democrats Embrace Aggressive Step on Drug Prices – 10.9.2019 Michigan Wants to Save $40 Million By Cutting PBMs Out of Medicaid – 10.8.2019 Buttigieg Unveils An Aggressive Plan for Lowering Drug Prices – 10.7.2019 Lower Drug Costs Now – 10.4.2019 Letter to FTC From Professor Michael Carrier Expressing Concerns About AbbVie-Allergan Merger – 10.3.2019 House Progressives Circulate Letter Seeking Changes to Pelosi Drug Pricing Bill – 9.30.2019 Political Tensions Escalate As Drug Pricing Bills Move Forward – 9.26.2019 Force Drug Companies to Lower Prices – 9.26.2019 You Might Be Surprised At How Far Americans Are Willing to Go Overthrow the Power of Big Pharma – 9.25.2019 Holding Pharmacy Benefit Managers Accountable is Crucial in Delaware – 9.24.2019 Medication Or Housing: Why Soaring Insulin Prices Are Killing Americans – 9.23.2019 Democrats’ Drug Price Bill May Be Dead on Arrival – 9.20.2019 Pelosi’s Drug Plan Would Let U.S. Negotiate Prices of 250 Medications – 9.19.2019 Lawmakers Ask FTC to Scrutinize Pharma Mergers Over Antitrust Concerns – 9.17.2019 Hey, FTC, Unions Say: AbbVie-Allergan Deal Needs Close Look After ‘Anticompetitive’ History – 9.13.2019 Consumer Groups, Unions Urge Caution on $63 Billion AbbVie Deal for Allergan – 9.12.2019 Consumer Groups, Unions Express Concerns About AbbVie-Allergan Merger – 9.12.2019 Pelosi Energizes Battles to Lower Drug Prices – 9.10.2019 The Trump-Pelosi Mind Meld on Drug Costs – 9.9.2019 Congress’ Fall To Do List: Guns, Spending, Drug Prices, Trade, Investigations – 9.9.2019 As Congress Considers Lowering Drug Costs, Pharma CEOs Target Key Senators With Campaign Cash – 9.3.2019 The $6 Million Drug Claim – 8.25.2019 Brand-name Drug Prices Rising At Slower Pace, Lower Amounts – 8.19.2019 Community Pharmacies Struggle to Stay Open – 8.17.2019 Cummings, Sanders Reopen 2014 Probe Into Generic Drug Price Fixing – 8.14.2019 The Window for Congress to Do Something on Drug Prices Won’t Be Open Forever – 8.14.2019 Canadians Are Hopping Mad About Trump’s Drug Importation Plan. Some of Them Are Trying to Stop It – 8.12.2019 Sens. Alexander and Murray Take a Bipartisan Step Forward on Drug Pricing – 8.7.2019 How Trump’s Plan to Import Canadian Drugs Would Work – 8.6.2019 2020 Election Creates ‘Perfect Storm’ For Drug Price Reform By Year-End – 8.5.2019 Cancer Patients Are Being Denied Drugs, Even With Doctor Prescriptions and Good Insurance – 8.2.2019 Congress is Going After Drug Prices. Pharma CEOs Aren’t Panicking, Yet – 8.2.2019 Trump Proposes Importing Medicines But He’s Really Seeking a Quick Political Fix – 8.1.2019 A Massive U.S. Drug Price-Fixing Probe Has Hit Major Roadblocks – 7.30.2019 Blumenthal Provides Common Sense Solution to Drug Pricing Crisis – 7.30.2019 Proposed Senate Act Would Restrict Pharmacy Benefit Managers – 7.29.2019​Sens. Kennedy, Cassidy, Others Introduce Legislation to Cut Costs of Prescription Drugs – 7.25.2019 GOP Can’t Agree on The Government’s Role in Forcing Down Drug Prices – 7.25.2019 Senate Committee Advances Drug Price Bill But GOP Opposition Could Doom Effort – 7.25.2019 Summer Setbacks: The Long Road to Lower Drug Prices Hits Some Potholes – 7.24.2019 Kentucky Group Fighting to Stop Insulin Price Hikes – 7.23.2019 Senate Releases Bipartisan Proposal to Lower Seniors’ Drug Prices – 7.23.2019 Senate Finance Pushes Ahead on Plan to Address High Drug Prices – 7.23.2019 Drug Price Transparency Prompts Fight Among Democrats – 7.22.2019 CVS-Aetna Merger: AHF Urges Court to Stop 800 Pound Gorilla – 7.21.2019 Protect At All Costs: How the Maker of the World’s Bestselling Drug Keeps Prices Sky-High – 7.18.2019​Federal Judge Order Release of Dataset Showing Drug Industry’s Role in Opioid Crisis – 7.16.2019​Kamala Harris’s Plan to Reduce Prescription Drug Costs, Explained – 7.16.2019 Biden Puts Forth an Elaborate – And Aggressive – Plan To Lower Drug Prices – 7.15.2019 Are Prescription Drug Prices Going Down? – 7.15.2019 Pharmacy Benefit Managers Poised to Grab Money They’ve Already Paid to Ohio Pharmacists – 7.14.2019 Trump Drug Pricing Setbacks Put Pressure on Congress – 7.12.2019​Letter from Consumer Action and U.S. PIRG Opposing CVS-Aetna Merger – 7.12.2019 Trump Abandons Drug Pricing Proposal That Would Have Ended Certain Drug Rebates – 7.11.2019 President Trump Withdraws Plan to Eliminate Drug Price Rebates – 7.11.2019 Pharmaceutical Mergers and Megamergers Stifle Innovation – 7.10.2019 So Much for Trump’s Rule About Drug Prices in TV Ads – 7.9.2019 GOP Senators Raise Concerns Over Potential Deal to Lower Drug Prices – 7.9.2019 Dispute Over Reining in Drug Middlemen Key in Ohio Budget Impasse – 7.8.2019 How Congress Can Make Solid Strides on Drug Pricing Reform – 7.6.2019 Minnesota Aims For More Transparency on Drug Prices – 7.6.2019 Trump Suggests Executive Action on Drug Prices, With a Scope That Is Unclear – 7.5.2019​Trump Craves Big Action on Drug Prices to Take to The Campaign Trail – 7.3.2019 Trump Fixates on Drug Prices As Campaign Looms – 7.2.2019 Maryland’s Path to A Prescription Drug Affordability Board – 7.1.2019 Questions Surround the Role of Pharmacy Benefit Mangers In Driving Drug Prices – 6.28.2019​Senate Finance Leaders in Talks On Deal To Limit Drug Price Increases – 6.26.2019 It’s a A Big Week For Debates About Drug Prices, Whether Pharma Likes It Or Not – 6.25.2019 We Can Work At State Level to Curb Prescription Drug Prices, Says Assemblywoman Hardy – 6.24.2019 Gov Mills to Sign 4 Bills to Reduce Medication Prices, Including Buying From Canada – 6.24.2019 The Health 202: White House is Reviewing a New Index to Cut Medicare Drug Spending – 6.21.2019 Drug Prices and Innovation – 6.20.2019 Grassley Announces Opposition to Key Trump Proposal To Lower Drug Prices – 6.19.2019 As the Price of Insulin Soars, Americans Caravan to Canada for Lifesaving Medicine – 6.16.2019 Drug Prices Are a Populist Campaign Issue. Here Are The Latest Proposals to Lower Costs – 6.16.2019 Lawmakers Fail to Override 4 Vetoes by Steve Bullock – 6.14.2019​We Either Buy Insulin Or We Die – 6.13.2019 House Progressives Challenge Drug Makers to Come Back to Capitol Hill – 6.12.2019 Senate Judiciary Committee Plans Markup Of Drug Pricing Bill This Month – 6.12.2019 Drug Plan Middlemen Under Scrutiny – 6.12.2019 Florida Governor Signs Bill for Foreign Drug Importation – 6.11.2019​CBO Analysis Doesn’t Tell Full Story on HHS’ Drug Pricing Reform – 6.10.2019 State Audit to Identify Users of Rx Managers; Senator Seeks Analysis, Study of Complaints – 6.8.2019 No End in Sight to Rising Drug Prices, Study Finds – 5.31.2019​Conflict Brews Over Fairness of High-Stakes CVs-Aetna Hearing – 5.30.2019​A $2.1 Million Drug Price Record is Made to Be Broken – 5.29.2019 Colorado Caps Insulin Co-Pays at $100 for Insured Residents – 5.24.2019​Federal Judge Wants Unrestrained Review of Proposed $69 Billion Merger of CVS, Aetna – 5.23.2019 To Slash Prices, Colorado Moves to Import Prescription Drugs – 5.21.2019​Senate Chairman Says Bipartisan Health Care Package Coming Thursday – 5.21.2019​House Lawmakers Question Whether Transparency Would Fix Drug Prices – 5.21.2019 Michael Bennet, Cory Gardner Fight to Bring Down Drug Prices – 5.20.2019 Collusion Over Drug Prices: Will Generic Manufacturers Pay? – 5.20.2019 How Big An Issue Is the Cost of Prescription Drugs? So Big That the 2019 Minnesota Legislature Actually Managed To Pass a A Bill Addressing It – 5.17.2019 FTC Must Tackle Anti-Competitive Drug Rebate Practices – 5.17.2019 House To Vote On Bills To Lower Drug Prices But Republicans Balk at Obamacare Protections – 5.16.2019 CMS Seeks to Limit ‘Spread Pricing’ by PBMs in Managed Care – 5.15.2019 Governor Vetoes New Regulations on Pharmacy Benefit Managers – 5.10.2019 The Prescription Pricing for the People Act – 5.10.2019 Comments Submitted in Support of CREATES Act on Behalf of Consumer Groups – 5.7.2019 Drug Industry Patents Go Under Senate Judiciary Committee’s Microscope – 5.7.2019 House to Vote on Bills to Update FDA’s Purple and Orange Books This Week – 5.6.2019 A Bipartisan Congress Is Moving Quickly on Pharmacy Benefit Managers – 5.1.2019 House Democrats Introduce Moderate Medicare Expansion Plan – 5.1.2019 States Pursue Aggressive Drug Pricing Remedies; PBMs, Big Pharma in Crosshairs – 5.1.2019 Bipartisan Bill Introduced to Increase Transparency, Accountability In Drug Pricing – 4.30.2019 Democrats Search for Drug Pricing Agreement – 4.29.2019 Trump Needs Help from Pelosi To Notch A Big Pricing Win – 4.29.2019 Movement to Reform Pharmacy Middlemen Reaches A Boiling Point Nationwide – 4.29.2019​Testimony in Support of Maine Bill LD 1504, Which Would Regulate Pharmacy Benefit Managers and Lower Drug Prices – 4.24.2019 Specialty Drugs; The New Arena for Pharmacy Benefit Manager Profits – 4.23.2019 In Possible Blueprint for Other States, Ohio Attorney General Floats Proposal to Rein in PBMs – 4.22.2019 Meet the 7 Witnesses Lining Up to Testify Against CVS-Aetna Next Month – 4.22.2019 Time To End Pharmacy Benefit Manager Price Gouging – 4.20.2019 Letter to Hawaii Insurance Commissioner Colin Hayashida Urging Measures Against PBMs – 4.19.2019 Trial in CVS-Optum Secrecy Case Delayed Again – 4.19.2019 Cummings Accuses Republicans of Obstructing Drug Prices Investigation – 4.17.2019 Grassley, Wyden Ask HHS Watchdog to Investigate Middlemen ‘Spread Pricing’ – 4.10.2019 “I Don’t Know How You People Sleep At Night”: Visibly Irate Lawmakers Blast Lawmakers, PBMs Over Insulin Prices – 4.10.2019 House Energy and Commerce Committee Holds Hearing on Rising Insulin Prices – 4.10.2019 PBMs Sidestep the Senate’s Tough Questions- But Lawmakers Hint At Legislation – 4.9.2019 Why I am Stockpiling Insulin In My Fridge – 4.9.2019 CVS, Cigna, Humana Blame Big Pharma at Senate Hearing for Skyrocketing Drug Prices – 4.9.2019 These Senators Received the Biggest Checks from CVS, Humana, and Other Pharmacy Benefit Managers Testifying Tuesday – 4.9.2019 This Week, Five Pharmacy ‘Middlemen’ Head to Capitol Hill’s Hot Seat. Some of Them Have an Easier Defense Than Others – 4.8.2019 Oversight Republicans Accuse Cummings of Partisan Drug Pricing Probe – 4.5.2019 Federal Judge to Hear Witness Testimony in Review of Aetna and CVS Merger DOJ Approval – 4.5.2019 Powerful House Committee To Weigh Legislation Aimed At Shedding More Light On High Drug Prices – 4.4.2019 The Absurdly High Cost of Insulin, Explained – 4.3.2019 Key House Lawmakers Reach Bipartisan Deal to Advance Long-Stalled Drug Pricing Bill – 4.3.2019 Ohio Legislators Frustrated At Slow Pace of PBM Reforms – 4.3.2019 Grassley, Wyden Question Role Of Middlemen in Skyrocketing Insulin Prices – 4.2.2019 Why PBMs’ Flawed Efforts to Stop Sensible Reform Won’t Work This Time – 4.3.2019 Cigna’s Express Scripts PBM to Cap Insulin Costs Amid Drug Price Scrutiny – 4.3.2019​Imported Canadian Prescription Drugs Set To Begin Selling in Florida – 3.28.2019​An HIV Treatment Cost Taxpayers Millions. The Government Patented It. But a Pharma Giant is Making Billions – 3.26.2019 White House and Pelosi’s Staff In early Talks About Legislation To Cut High Drug Costs – 3.26.2019 Big Pharma’s Go-To Defense of Soaring Drug Prices – 3.23.2019​Comments in Support of Minnesota Bill to Regulate PBMs – 3.26.2019 How Maine Is Battling Exorbitant Drug Prices – 3.23.2019 States Are Tackling America’s Drug Pricing Problem – 3.23.2019 Kentucky Probes Pharmacy Benefit Managers For Allegedly Overcharging State Medicaid – 3.22.2019 Why Should Americans Be Grateful for $138 Insulin? Germans Get It for $55 – 3.21.2019 Partisan Squabbles Shadow Congress’s Efforts to Lower Drug Prices – 3.20.2019 A Drug Pricing Mystery: Who’s Behind All the Outrage Over Rebates? – 3.19.2019 Survey: About 1 in 10 Americans Rationing Medicine In Effort to Lower Costs – 3.19.2019​Floridians Could Soon Avoid Soaring U.S. Prescription Drug Prices – 3.18.2019​Comments in Support of Ohio Bill to Regulate Pharmacy Benefit Managers – 3.18.2019​House Energy and Commerce Committee Addresses Seven Bills to Improve Generic Competition – 3.13.2019​Key Senators Call Five Pharmacy Middlemen to Testify About Drug Prices – 3.12.2019 Senate Panel Asks CVS and Four Other Pharma Middlemen to Testify About Drug Prices – 3.12.2019 One GOP Senator Is Urging The Drug Industry To Make Good on Lowering Drug Prices – 3.6.2019 Treat Medicine Like Netflix Treats Shows – 3.5.2019 Liberal Groups Call On Dem Leaders to Go Bigger on Drug Pricing – 2.28.2019 Proposal to Regulate Pharmacy Benefit Mergers Passes Out of Senate – 2.27.2019 Congress Could Have Been Tougher on Drug Executives – 2.27.2019 Pharmaceutical Company CEOS Face Grilling in Senate Over High Drug Prices – 2.26.2019 US Asks Judge to Give Final Approval to Settlement With CVS to Buy Aetna – 2.26.2019 Senators Must Get to the Root of High Drug Prices – 2.25.2019 Kentucky Finds PBMs Are Benefiting From a Lucrative Profit Center – 2.21.2019 Yost Promises More Action Against Pharmacy Middlemen: ‘They Took Our Money’ – 2.20.2019 Drug Pricing Fight Centers on Insulin – 2.20.2019​Attorney General Dave Yost Seeking $16 Million Repayment From Pharmacy Middlemen OptumRx – 2.19.2019 Kentucky Medicaid Releases Report on Pharmacy Benefit Program – 2.19.2019 A Step Forward on Drug Prices Should Not Be Overlooked – 2.14.2019 Analyst: State’s New Drug Setup Still Riddled With Loopholes – 2.10.2019 To Control Drug Prices, States May Have to Face off Against the Feds – 2.10.2019 Time To Remove Texas’s Drug Middlemen – 2.10.2019 Dems Unveil Bill for Medicare To Negotiate Drug Prices – 2.7.2019 As Trump Calls on Congress to Lower Drug Prices, Some Democrats Cheer. Others Scoff. – 2.6.2019 PBMs Launch Counterattack Following Trump Administration’s Plan to End Drug Rebates – 2.6.2019​Democrats Bat Away Trump’s Olive Branch on Drug Pricing – 2.5.2019 Uncertainties Remain In Trump Rebate Plan – 2.4.2019 Testimony in Support of Montana’s SB 71- Bill to Regulate Pharmacy Benefit Managers – 2.1.2019​DeWine Wants Crackdown On Pharmacy Middlemen, Managed Care Groups – 2.1.2019 Bill Goes After Middlemen In Effort To Lower Prescription Drug Prices In Montana – 2.1.2019 Trump Officials Move To Lower Drug Prices By Passing Rebates On To Patients – 1.31.2019 The Trump Administration Is Taking On Middleman That Inflate Drug Prices – 1.31.2019 CVS Bought Your Local Drugstore, Mail-Order Pharmacy and Health Insurer. What’s Next, Your Hospital? – 1.31.2019 On Both Ends of Capitol, Both Parties Warn Big Pharma on Drug Prices – 1.29.2019 Comprehensive Reform to Lower Prescription Drug Prices – 1.29.2019 Drug-Pricing Policies Find New Momentum As ‘A 2020 Thing’ – 1.29.2019 Why Drug Prices Keep Going Up-And Why They Need to Come Down – 1.29.2019 Indian Tribe Joins Big Pharma At the Supreme Court, Defending a Lucrative Deal – 1.26.2019 Pharmacy Benefit Managers Marked Up Generic Drugs for NY Medicaid, But Where Did The Money Go? – 1.24.2019 Drug Middlemen Got Big Markup In New York, Pharmacists Say – 1.24.2019 Baker Outlines Steps to Lower Drug Prices – 1.24.2019 Looking to 2020, Democrats Take On Prescription Drug Prices – 1.24.2019​U.S. Insulin Costs Nearly Doubled From 2012 to 2016, Study Finds – 1.22.2019 Big Pharma Lobby Group Spent Record Amount As Reform Push Grows – 1.22.2019 Hill Drug Pricing Scrutiny Starts With Patients, Researchers – 1.22.2019 Maryland Could Become First State to Cap Prescription Drug Costs – 1.22.2019 Secret ‘Rebate Trap’ Strategy Blocks Patients from Buying Generic Drug – 1.18.2019​FDA Directs Dwindling Resources Toward Reviewing New Drugs – 1.17.2019 HHS Secretary Azar is Courting Capital Hill on Drug Prices – 1.17.2019 Dem Chairman Cummings Meets With Trump Health Chief To Discuss Drug Prices – 1.15.2019 Prescription Drug Pricing Strategy: Where Is the Money Going? – 1.14.2019 House Democrats Launch Drug Pricing Probe Into a Dozen Major Health-Care Companies – 1.14.2019 All Congress’s Ideas for Bringing Down Prescription Drug Prices, Explained – 1.14.2019 Skoufis Targets Prescription Drug Pricing – 1.11.2019 As Congress Returns, Lawmakers Rush to Detail Drug Pricing Agendas – 1.9.2019​Pharmacist Fights for Livelihood, Drug Cost Transparency – 1.9.2019 Democrats Look to Unlikely Ally on Drug Pricing: Donald Trump – 1.4.2019 This Bottle of Pills Costs $20 in One State and $130 in Another – 1.4.2019 Drugmakers Raise Prices on Hundreds of Medicines – 1.1.2019 As Drug Prices Soar, Policymakers Eye Dose of Government Intervention – 12.20.2018 Judge Seeks Monitoring of CVS and Aetna During Antitrust Review – 12.18.2018 Warren Bill Would Get Feds Into Generic Drug Manufacturing – 12.17.2018​Consumer Groups Submit Comments Opposing CVS and Aetna Merger – 12.17.2018 DeWine Must Make Medicaid PBM Reform a Top Priority – 12.16.2018​Establishment Looks to Crush Liberals on Medicare For All – 12.10.2018​Investigation of Generic ‘Cartel’ Expands to 300 Drugs – 12.9.2018 Ohio Leads the Way As States Take On ‘Pharmacy Benefit Manager’ Middlemen – 12.7.2018 Merged CVS-Aetna Won’t Extend Transparency, Competition Guarantees – 12.4.2018 U.S. Judge Concerned Over Government Nod for CVS Deal – 12.4.2018 Drug Rebate Walls Should Be Dismantled by the FTC’s Antitrust Arm – 12.4.2018 FOIC Still Fighting for Disclosure of Insurance Acquisitions – 12.3.2018​A Return to ‘Dollars and Sense’ Antitrust Enforcement – 11.30.2018 Senator Jeff Merkley Targets Big Pharma With Bill to Lower Prescription Drug Prices – 11.29.2018 Attacking Monopoly Power Can Be Stunningly Good Politics, Survey Finds – 11.28.2018 CVS Creates New Health-Care Giant As $69 Billion Merger With Aetna Officially Closes – 11.28.2018 Chronically Ill, Traumatically Billed; The $123,000 Medicine for MS – 11.28.2018 Grassley’s Move to Finance Committee Could Bolster Drug Price Efforts – 11.26.2018 Why Prescription Drug Prices Have Skyrocketed – 11.26.2018 America’s Monopoly Problem, In One Chart – 11.26.2018​The Monopolization of America – 11.25.2018 More Americans Trust Democrats Than GOP to Lower Drug Prices – 11.21.2018 CVS Now Expects Aetna Acquisition to Close After Thanksgiving – 11.20.2018 The Bernie Sanders-Trump Mind Meld on Drug Costs – 11.20.2018 Axios Deep Dive on Drug Prices – 11.19.2018 Pfizer to Raise Prices on 41 Prescription Drugs Next Year Despite Pressure From Trump – 11.16.2018​More States, Including Pennsylvania, Are Taking on Pharmacy Benefit Managers, Demanding to See The Savings in Medicaid – 11.9.2018 Rep. Peter Welch on Drug Prices, the Potential for Bipartisan Action, and a Broken Market – 11.9.2018 House Election Results: Democrats Take Control – 11.7.2018 CVS Expects Deal With Aetna to Close By Thanksgiving – 11.6.2018 Prescription Drug Prices: A Bitter Pill in the Midterm Elections – 10.31.2018 Pharma’s ‘Come-to-Jesus’ Moment: The Industry Braces for a Pelosi Speakership and Democrats’ Drug Pricing Agenda – 10.30.2018 Abuse of U.S. Patent System Drives High Drug Prices – 10.27.2018 Trump Proposed to Lower Drug Prices By Basing Them on Other Countries’ Costs – 10.25.2018 Claire McCaskill is Campaigning As Pharma’s Sworn Enemy–And That’s the Way She Wants It – 10.24.2018 State Regulators Probe CVS Drug Price Fluctuations – 10.23.2018 Oregon Health Experts Call for Transparency, Competition, State Action on Drug Pricing – 10.23.2018 Winter Is Coming’: Companies Brace For Flurry of Investigations – 10.22.2018​Trump’s Trade Deal Includes Major Win For Pharma – 10.2.2018 President Trump Unveils Plan to Lower Prescription Drug Prices – 5.11.2018  Trump Surrenders In the War on Drug Prices – 5.11.2018 ​AT&T, Novartis CEOs Apologize for Payments to Michael Cohen – 5.11.18  Trump to Deliver Major Address on Drug Prices, But Advocates Predict Small Steps – 5.4.2018 The CVS-Aetna Merger Will Be A Disaster for Small Drugstores – 12.15.2017 Drug Industry Lawsuit Shows It Wants To Keep Patients in the Dark – 12.15.2017 Follow the Money to Understand How Drug Profits Flow – 12.15.2017 Experts Tell Congress How to Cut Drug Prices. We Give You Some Odds – 12.12.2017  When Buying Prescription Drugs, Some Pay More With Insurance Than Without It – 12.9.2017  Drug Companies Sue California Over Drug Price Transparency Law – 12.8.2017 ​CVS-Aetna Merger is a Robber Baron’s Dream Come True – 12.6.2017 New Mega-Deal Shows How Health Insurers Are Taking Over Your Access to Health Care – 12.7.2017 Trump Is Mum on Report Showing How We Can Reduce Sky-High Drug Prices – 12.7.2017  The CHIP Program is Beloved. Why Is Its Funding In Danger? – 12.5.2017 Will CHIP Crumble? States Are Getting Nervous – 12.4.2017 Trump Administration is Taking on Drug Prices – But Not Drug Companies – 11.24.17 HHS Pick At Odds With Trump’s Rhetoric on Drug Prices – 11.15.17 What Would Happen If Medicare Started Negotiating Drug Prices – 11.14.17 Drug Costs in the Spotlight With Trump’s Pick for Health Secretary – 11.14.17 Trump Picks Ex-Pharma Executive Azar to Lead HHS – 11.13.17 PBM DIR Fees Costing Medicare and Beneficiaries: Investigative White Paper on Background, Cost Impact, and Legal Issues – 11.8.17 Trump Talks Tough But Little Action Seen on Drug Prices – The Hill 11.1.17 CVS-Aetna Deal Could Have Same Result As Telecom Mergers – Higher Prices – Los Angeles Times 10.31.17 CVS Bid for Aetna Followed Long Hunt – Wall Street Journal 10.28.17 Why CVS Health Would Want to Buy Aetna – Washington Post 10.26.17 Frustrated With Trump, Democrats Introduce Drug Pricing Bill – The Hill 10.25.17 California Just Passed A Law To Reign In Drug Prices. Here’s Why It’s Unlikely to Make Much Difference – STAT 10.24.17 AMA Study Says Competition Among Health Insurers is Shrinking – Modern Healthcare 10.24.17 When Paying for Drugs With Insurance Costs More Than Paying Cash: Bill Would Require Pharmacists to Let Their Customers Know – Massachusetts Live 10.23.17 Cancer Drug Prices Rising Far Faster Than Inflation – Business Insider 10.18.17 Patents for Restasis Are Invalidated, Opening Door to Generics – New York Times 10.16.17 Trump Renews Attacks on High Drug Prices – Politico 10.16.17 Have High Drug Prices Finally Reached a Tipping Point? – Healthline News 10.12.17 Battle Over Drug Prices Shifts Back to the States – The Hill 10.11.17 California Governor Signs Drug Pricing Transparency Law – Reuters 10.9.17 Senator McCaskill Drafts Bill in Response to Allergan Patent Maneuver – Reuters 10.5.17 California Bill Would Compel Drugmakers to Justify Price Hikes – National Public Radio 10.4.17 Scott Gottlieb Rocketed to the Top of FDA. He May Keep Rising – STAT 10.4.17 Grassley Pressing to Include Drug Pricing Measures in CHIP Reauthoriztion – Morning Consult 10.3.17​Pfizer Exposes the Sordid Underbelly of Drug Pricing – USA Today 10.3.17 The Pharma Industry Tried to Justify Drug Prices. We Fact-Checked Them – Huffington Post and Kaiser Health News 9.29.17 Absent Federal Action, States Take the Lead on…